Effects of conventional and aggressive statin treatment on markers of endothelial function and inflammation
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Background: Atherosclerosis is considered to be a chronic inflammatory disorder. Several large‐scale clinical studies demonstrate that markers of inflammation, such as high‐sensitivity C‐reactive protein (hsCRP), fibrinogen, and soluble CD40 ligand, are potent and independent predictors of vascular risk. Hypothesis: The study was undertaken to investigate the effect of increasing the statin dose from conventional to aggressive treatment on lipids levels, inflammation, and endothelial function in patients with coronary artery disease (CAD). Methods: We randomized 97 patients to either 20 mg simvastatin or 80 mg atorvastatin. Plasma levels of lipids, hsCRP, fibrinogen, soluble adhesion molecules, and nitric oxide‐total were analyzed at baseline and after 6 months of treatment. Results: Lipid values were significantly reduced in both treatment groups, but with significantly greater reduction in the aggressively treated group. Furthermore, aggressive statin treatment significantly decreased hsCRP and fibrinogen, while only small reductions were seen in the conventionally treated group, resulting in significant differences between the two treatment groups (p < 0.001). Nitric oxide‐total increased significantly in both treatment groups, although the increase was more pronounced in the aggressively treated group (22.6 vs. 15.6%). Conclusion: Aggressive statin treatment significantly improved lipid status and reduced markers of inflammation and improved endothelial function compared with conventional treatment in patients with CAD. No interaction was observed, and high‐dose treatment did not offer additional benefit compared with standard‐dose treatment with respect to soluble adhesion molecules.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ridker, P. M. (2001) · Circulation · doi:10.1161/01.cir.103.13.1813 · Cited by 1,402
Cited by
Monocyte Telomere Shortening and Oxidative DNA Damage in Type 2 Diabetes
Sampson, M. J., Winterbone, M. S., Hughes, J. C., Dozio, N., & Hughes, D. A. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1715 · Cited by 344
Is Hypertension an Inflammatory Process?
Boos, C., & Lip, G. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206776843313 · Cited by 165
“For example, statin therapy has lead to significant reductions in levels of proinflammatory cytokines (TNF-α, IL-1 and IL-6) as well as in ICAM-1 and CRP [190-192].”
BackgroundKaplan, D. E., Serper, M. A., Mehta, R., Fox, R., John, B., Aytaman, A., Baytarian, M., Hunt, K., Albrecht, J., Njei, B., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.01.026 · Cited by 145
Praet, S. F. E., Jonkers, R. A. M., Schep, G., Stehouwer, C. D. A., Kuipers, H., Keizer, H. A., & van Loon, L. J. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0169 · Cited by 80
Metadata
- Authors
- Hognestad, A., Aukrust, P., Wergeland, R., Stokke, O., Gullestad, L., Semb, A., Holm, T., Andreassen, A. K., & Kjekshus, J. K.
- Venue
- Clinical Cardiology
- Publisher
- Wiley
- Published
- 2004-04
- Volume
- 27
- Issue
- 4
- Pages
- 199-203
- ISSN
- 0160-9289 (ISSN-L)
- 1932-8737
- OpenAlex
- W1614398818
- Cited by
- 49
- References
- 1
- FWCI
- 4.24
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.